ストックスクリーナーアプリを入手
141.77
0.13%
0.07
Neurocrine Biosciences Inc (NBIX) 最新ニュース
Neurocrine Bio. stock price target raised to $198 by H.C. Wainwright - Investing.com UK
Published on: 2025-12-18 16:31:37 - Улправда
HC Wainwright & Co. Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - Nasdaq
Neurocrine Biosciences (NASDAQ:NBIX) Director Leslie Norwalk Sells 1,190 Shares - MarketBeat
Neurocrine Biosciences (NASDAQ:NBIX) Director Leslie Norwalk Sells 5,000 Shares - MarketBeat
Neurocrine Biosciences Director Sells Shares - TradingView — Track All Markets
Neurocrine Bio. stock price target reiterated at $200 by TD Cowen - Investing.com Canada
Key facts: HC Wainwright maintains 'Buy' on Neurocrine; price target rises - TradingView — Track All Markets
Neurocrine Bio. stock holds Buy rating at Jefferies after R&D Day - Investing.com Canada
Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Neurocrine Bio. stock rating reiterated at Outperform by RBC Capital - Investing.com Canada
Texas Permanent School Fund Corp Sells 11,976 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine showcases R&D across neuroscience and endocrinology - The Pharma Letter
Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology - PR Newswire
What analysts say about Neurocrine Biosciences Inc stockMomentum Trading Signals & Free Daily Top Stock Picks for All Investors - earlytimes.in
Dir Norwalk Files To Sell 11,250 Of Neurocrine Biosciences Inc [NBIX] - TradingView — Track All Markets
Hudson Bay Capital Management LP Has $9.75 Million Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences (NBIX): Revisiting Valuation After a Year of Double-Digit Shareholder Returns - simplywall.st
Thrivent Financial for Lutherans Cuts Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
Boone Capital Management LLC Makes New Investment in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences, Inc. $NBIX is Braidwell LP's 3rd Largest Position - MarketBeat
Ieq Capital LLC Buys 35,956 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Mizuho raises Neurocrine Bio. stock price target to $175 on Crenessity outlook - Investing.com India
Mizuho maintains Neurocrine Biosciences (NBIX) neutral recommendation - MSN
Stifel Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - Nasdaq
Stifel Nicolaus Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price - MarketBeat
How Neurocrine Biosciences Inc. (NBIX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Neurocrine Biosciences chief legal officer Lippoldt sells $698k in stock - Investing.com Canada
Neurocrine Bio. stock rating reiterated at Buy by TD Cowen - Investing.com Canada
Neurocrine Biosciences (NASDAQ:NBIX) Insider Sells $698,628.40 in Stock - MarketBeat
Neurocrine Biosciences Insider Sold Shares Worth $698,615, According to a Recent SEC Filing - marketscreener.com
Officer Lippoldt Sells 4,376 ($698.6K) Of Neurocrine Biosciences Inc [NBIX] - TradingView — Track All Markets
Diadema Partners LP Has $11.82 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences, Inc. $NBIX Shares Purchased by Axa S.A. - MarketBeat
Amundi Has $28.36 Million Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences to Host R&D Day on December 16 - Sahm
Arrowstreet Capital Limited Partnership Acquires 58,562 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
RBC Capital Maintains Neurocrine Biosciences (NBIX) Outperform Recommendation - Nasdaq
Officer Lippoldt Files To Sell 4,376 Of Neurocrine Biosciences Inc [NBIX] - TradingView — Track All Markets
RBC Capital Initiates Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $180 - 富途牛牛
Neurocrine Biosciences (NASDAQ:NBIX) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
Neurocrine Biosciences stock hits 52-week high at $157.88 By Investing.com - Investing.com Canada
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $180.00 - MarketBeat
Neurocrine Biosciences stock hits 52-week high at $157.88 - Investing.com
RBC Raises Price Target on Neurocrine Biosciences to $180 From $160, Keeps Outperform Rating - marketscreener.com
Hood River Capital Management LLC Sells 79,626 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Bio. stock price target raised to $180 from $160 at RBC Capital - Investing.com
First Trust Advisors LP Lowers Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
1832 Asset Management L.P. Purchases New Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences (NBIX) valuation update after NBI-1070770 Phase 2 trial failure reshapes pipeline expectations - Sahm
Earnings Recap: How Neurocrine Biosciences Inc stock performs in weak economyWeekly Trade Report & High Accuracy Trade Alerts - moha.gov.vn
TD Cowen Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price - MarketBeat
Growth Value: How MSPRO stock compares to industry benchmarksQuarterly Performance Summary & AI Powered Market Entry Strategies - BỘ NỘI VỤ
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Brown Advisory Inc. - MarketBeat
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TD Cowen Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - Nasdaq
Leading Drug Stock Fights To Regain Buy Point At Key Resistance Level - Investor's Business Daily
Saturn V Capital Management LP Makes New Investment in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Will Neurocrine Biosciences Inc. stock split again soonWeekly Loss Report & Free Fast Gain Swing Trade Alerts - Newser
Neurocrine Bio. stock price target raised to $200 from $175 at TD Cowen By Investing.com - Investing.com South Africa
Neurocrine Bio. stock price target raised to $200 from $175 at TD Cowen - Investing.com India
Why Neurocrine Biosciences Inc. (NB3) stock stays on buy listsPortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
1.07%
1.14%
大文字化:
|
ボリューム (24 時間):